CATX

Perspective Therapeutics Stock Analysis

AI Rating

Neutral
  • Quality4/10
  • Growth↑ 5/10
  • Momentum↑ 9/10
Perspective Therapeutics sales and earnings growth
CATX Growth
Neutral
  • Revenue Y/Y↓ -30.96%
  • EPS Y/Y↓ 3.23%
  • FCF Y/Y↓ -162.13%
Perspective Therapeutics gross and profit margin trends
CATX Profitability
Low
  • Gross margin ↑ 100.00%
  • EPS margin↓ -9841.90%
  • ROIC↓ -49.80%
Perspective Therapeutics net debt vs free cash flow
CATX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -450.4

Perspective Therapeutics stock volatility is in-line with the overall market. We give it a Great risk rating.

More Medical Devices stocks ↗